I am a
Home I AM A Search Login

Papers of the Week

2020 Apr

J Heart Lung Transplant



Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience.


Barghash MH, Taimur S, Rana M, Behar J, Lala A, Mitter SS, Moss N, Pinney SP, Mancini D
J Heart Lung Transplant. 2020 Apr; 39(4S):S204.
PMID: 32465067.


Herpes zoster (HZ) results from reactivation of latent varicella zoster virus (VZV) presenting as a dermatomal rash. Diminished cellular immunity to VZV increases HZ risk and incidence in solid organ transplant (SOT) is higher than the general population. Immunogenicity and safety of the inactivated varicella vaccine (RZV, Shingrix) has been demonstrated in renal transplant (KT) but data in heart transplant (HT) are lacking.